Fresh disappointment for Innate’s Astra lifeline

cafead

Administrator
Staff member
  • cafead   Aug 01, 2022 at 10:52: AM
via With Lumoxiti confirmed as commercially unviable monalizumab fails its phase 3 trial in head and neck cancer.

article source